Powell’s speech, Nvidia’s chips, Meta deal - what’s moving markets
Director Maryland Patricia Anne sold 20,018 shares of Surgery Partners Inc. (NASDAQ:SGRY) common stock on August 11, 2025, for $455209. The price for the shares was $22.74, below the current trading price of $23.55. The $3 billion market cap healthcare company has seen volatile stock movements, with prices ranging from $18.87 to $33.97 over the past year. According to InvestingPro analysis, the stock appears slightly overvalued at current levels, with analysts maintaining a strong buy consensus and a high price target of $36.
Following the transaction, Maryland Patricia Anne directly owns 4,565 shares of the company. While the company isn’t currently profitable, analysts tracked by InvestingPro expect positive earnings this year, with an EPS forecast of $0.90. Get access to more exclusive insights and detailed analysis in the comprehensive Pro Research Report, available with an InvestingPro subscription.
In other recent news, Surgery Partners reported its second-quarter 2025 earnings, surpassing analysts’ expectations. The company achieved an earnings per share (EPS) of $0.17, exceeding the projected $0.16. Revenue for the quarter was $826 million, slightly above the anticipated $819.45 million. Additionally, Surgery Partners reiterated its fiscal year 2025 guidance, although it now expects results to fall in the lower half of the projected ranges. Benchmark reiterated a Buy rating for Surgery Partners, maintaining a price target of $35.00, highlighting the company’s solid positioning. Capital deployment has been modest, with only $66 million reached year-to-date and $12 million committed since March 31, which is below the annual target of at least $200 million. These developments reflect recent financial and strategic updates from the company.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.